To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
The Legal Information Series is offered to give patients answers to their questions regarding legal situations associated with cancer including social security, powers of attorney, end of life decisions and more.
More Information
If you have questions or need more information on the Legal Information Series, please call 313-576-9700.
A diagnosis of cancer can trigger a number of legal issues. The program was designed to provide legal information, resources, and representation to low-income patients who are otherwise unable to afford legal services.
Legal staff and students will be available to Karmanos patients to answer your questions on legal issues about:
Please call our Patient and Community Education Department at 313-576-9288 for more information.
Lung cancer survivor encourages others to quit smoking and advocates for cancer screenings WDET - Susie Lawrence, Ph.D. says joining the Lung Canc...
Prostate, lung, colorectal and skin cancers are the most common cancers diagnosed among men, and one of the best weapons in fighting cancer is pre...
Originally posted on KevinMD.com Why does one person respond favorably to lung cancer treatment while another does not? The answer lies in the DNA...